37.74
Harmony Biosciences Holdings Inc Stock (HRMY) Latest News
Demystifying Harmony Biosciences: Insights From 5 Analyst Reviews - Benzinga
Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from Analysts at Deutsche Bank Aktiengesellschaft - MarketBeat
Deutsche Bank sets Harmony Biosciences stock Buy rating, $55 target - Investing.com
Polaris Capital Management LLC Has $2.01 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Deutsche Bank Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy - StreetInsider.com
(HRMY) Proactive Strategies - Stock Traders Daily
Is Harmony Biosciences Holdings Inc. (HRMY) a Biotech Stock to Consider? - StockNews.com
BlackRock, Inc.'s Strategic Acquisition in Harmony Biosciences H - GuruFocus.com
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance
Top 5 US Stocks To Buy In February 2025 - Investing.com
SG Americas Securities LLC Grows Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
HRMY vs. RGEN: Which Stock Is the Better Value Option? - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CFO Sandip Kapadia Sells 1,775 Shares - MarketBeat
Insider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Sells 1,629 Shares of Stock - MarketBeat
Jeffrey Dierks Sells 13,125 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock - MarketBeat
Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here's What You Should Know - MSN
Vanguard Group Inc. Expands Stake in Harmony Biosciences Holdings Inc. - GuruFocus.com
Harmony Biosciences Stock Scores 80-Plus RS Rating - Yahoo! Voices
Harmony Biosciences' chief commercial officer sells $551,575 in stock - MSN
H.C. Wainwright maintains $75 target on Harmony Biosciences stock - MSN
Harmony Biosciences' chief commercial officer sells $551,575 in stock By Investing.com - Investing.com Australia
Harmony Biosciences (NASDAQ:HRMY) vs. Werewolf Therapeutics (NASDAQ:HOWL) Head to Head Review - Defense World
H.C. Wainwright maintains $75 target on Harmony Biosciences stock By Investing.com - Investing.com Australia
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Position Boosted by Pacer Advisors Inc. - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Earns "Buy" Rating from HC Wainwright - MarketBeat
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com
Why Harmony Biosciences Shares Are Gaining Attention - TipRanks
Learn to Evaluate (HRMY) using the Charts - Stock Traders Daily
Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Insider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CEO Sells 19,293 Shares of Stock - MarketBeat
Sandip Kapadia Sells 25,000 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Trading Down 4.5%Here's What Happened - MarketBeat
Harmony Biosciences: Don't Sleep On This Enterprising, Profitable Biotech (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences CFO Sandip Kapadia sells $1m in stock By Investing.com - Investing.com Australia
Zacks.com featured highlights include Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes - Yahoo Finance
Harmony Biosciences CFO Sandip Kapadia sells $1m in stock - MSN
Cantor Fitzgerald Forecasts HRMY FY2025 Earnings - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 1,123 Shares - MarketBeat
Harmony Biosciences Reports Strong Revenue Growth and Outlines Ambitious 2025 Strategy - MSN
HRMY: 3 Under-the-Radar Biotech Stocks Revolutionizing Healthcare - StockNews.com
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
Equities Analysts Offer Predictions for HRMY FY2025 Earnings - MarketBeat
Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) PT at $55.00 - MarketBeat
Harmony Biosciences chief commercial officer sells shares worth $1.15m By Investing.com - Investing.com Canada
ARS Investment Partners LLC Invests $841,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):